Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Salem, Billan"'
Autor:
Bar Kaufman, Tarek Taha, Orli Abramov, Yaniv Zohar, Kamel Mhameed, Ofir Cohen, Angel Porgador, Moshe Elkabets, Salem Billan
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-7 (2024)
Abstract Therapies targeting the PD-1/PD-L1 pathway have transformed head and neck squamous cell carcinoma (HNSCC) treatment. However, predicting the response to anti-PD-1 therapy remains a clinical challenge. This study evaluated the functional bind
Externí odkaz:
https://doaj.org/article/d5f6768c30924b929faf4d6be7a889a4
Autor:
Jacob Bornstein, Koray Gorkem Sacinti, Mario Preti, Salem Billan, Hosna Razeghian, Colleen K. Stockdale
Publikováno v:
Gynecologic Oncology Reports, Vol 54, Iss , Pp 101445- (2024)
The WHO’s initiative to eliminate cervical cancer by 2030 does not address the increasing incidence of vulvar, anal, and oropharyngeal cancers linked to high-risk HPV. Currently, the prevention of these three cancers faces various obstacles, such a
Externí odkaz:
https://doaj.org/article/5bd12df18fdb455fb5dba4965c7ed9fd
Autor:
Åse Bratland, Eva Munoz-Couselo, Laurent Mortier, Osama Roshdy, Rene González, Jacob Schachter, Ana M. Arance, Florent Grange, Nicolas Meyer, Abhishek Jagdish Joshi, Salem Billan, Brett G. M. Hughes, Jean-Jacques Grob, Karthik Ramakrishnan, Joy Ge, Burak Gumuscu, Ramona F. Swaby, Ralf Gutzmer
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 12, Pp 3165-3180 (2023)
Abstract Introduction At first interim analysis of KEYNOTE-629, health-related quality of life (HRQoL) with pembrolizumab was stable or improved over 48 weeks in recurrent or metastatic (R/M) cutaneous squamous cell carcinoma (cSCC). HRQoL results fr
Externí odkaz:
https://doaj.org/article/c25ae9485a674062bd066049630a8b43
Publikováno v:
SAGE Open Medical Case Reports, Vol 12 (2024)
Colorectal cancer ranks third in cancer incidence in the United States, commonly metastasizing to the liver and lungs. Despite its high prevalence, colorectal cancer with intraocular metastasis is exceedingly rare, with only a few cases reported in t
Externí odkaz:
https://doaj.org/article/08d4c5e2af3c49fc8020cc755ce1aefe
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionThe aim of this study is to identify factors that may predict the response of locally advanced rectal cancer tumors (LARC) to neoadjuvant chemoradiotherapy (CRT) and to evaluate the effect of circulating lymphocytes on pathological tumor
Externí odkaz:
https://doaj.org/article/51a0def879764f04aacf9414fef572dd
Publikováno v:
Cancer Medicine, Vol 11, Iss 6, Pp 1484-1489 (2022)
Externí odkaz:
https://doaj.org/article/a4286f2850124536af485def523ba2f8
Autor:
Itamar Averbuch, Saeed Salman, Noa Shtamper, Ilana Doweck, Aron Popovtzer, Gal Markel, Daniel Hendler, Inbar Finkel, Assaf Moore, Eyal Fenig, Tarek Taha, Kamel Mhameed, Noga Kurman, Salem Billan
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectiveCutaneous squamous cell carcinoma (cSCC) is the second most common non-melanoma skin cancer worldwide. It is usually treated surgically, with very high cure rates. However, in 3%-7% of cases, cSCC metastasizes to lymph nodes or distant organ
Externí odkaz:
https://doaj.org/article/676bfb43c4f0472eb3d06c0b192ba688
Autor:
Ziv Gil, Salem Billan
Publikováno v:
Rambam Maimonides Medical Journal, Vol 13, Iss 2, p e0014 (2022)
In the management of malignant thyroid disorders, the standard primary treatment is thyroidectomy, a surgical resection of the thyroid gland. This procedure has been performed for over a century. Hence, it comes as no surprise that it is not only exc
Externí odkaz:
https://doaj.org/article/d2f6733a9f3a48e297e73935a6953e3e
Publikováno v:
Cells, Vol 11, Iss 9, p 1375 (2022)
Extracellular vesicles (EVs) are heterogamous lipid bilayer-enclosed membranous structures secreted by cells. They are comprised of apoptotic bodies, microvesicles, and exosomes, and carry a range of nucleic acids and proteins that are necessary for
Externí odkaz:
https://doaj.org/article/9d5c01e9e1474a88bbdb411195f74760
Publikováno v:
Anti-Cancer Drugs. 34:325-331
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e168633c646d03bfccf897b32163be39
https://doi.org/10.1097/cad.0000000000001411
https://doi.org/10.1097/cad.0000000000001411